WBA - Walgreens Boots Alliance, Inc.
NASDAQ
->
Healthcare
->
Pharmaceutical Retailers
Deerfield,
United States
Type: Equity
WBA price evolution
WBA
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $668 | $784 | ||
| Short term investments | ||||
| Net receivables | $6200 | $5972 | $5381 | |
| Inventory | $8557 | $9454 | $8257 | |
| Total current assets | $16561 | $17345 | $15503 | |
| Long term investments | $3256 | $3400 | $4236 | |
| Property, plant & equipment | $31463 | $32884 | $33254 | |
| Goodwill & intangible assets | $28798 | $41462 | $41822 | |
| Total noncurrent assets | $67646 | $80478 | $81125 | |
| Total investments | $3256 | $3400 | $4236 | |
| Total assets | $84207 | $97823 | $96628 | |
| Current liabilities | ||||
| Accounts payable | $12775 | $13593 | $12635 | |
| Deferred revenue | ||||
| Short long term debt | $4276 | $4020 | $3264 | |
| Total current liabilities | $24915 | $26116 | $24535 | |
| Long term debt | $29347 | $29717 | $30269 | |
| Total noncurrent liabilities | $43928 | $43950 | $43605 | |
| Total debt | $33623 | $33737 | $33533 | |
| Total liabilities | $68843 | $70066 | $68140 | |
| Shareholders' equity | ||||
| Retained earnings | $26448 | $32573 | $33058 | |
| Other shareholder equity | -$2897 | -$2995 | -$2993 | |
| Total shareholder equity | $13484 | $19481 | $20020 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1358 | $1193 | $516 | |
| Short term investments | $1114 | |||
| Net receivables | $5381 | $5017 | $5663 | $7132 |
| Inventory | $8257 | $8353 | $8159 | $9451 |
| Total current assets | $15503 | $16902 | $15814 | $18073 |
| Long term investments | $4236 | $5495 | $6987 | $7338 |
| Property, plant & equipment | $33254 | $32988 | $34140 | $35066 |
| Goodwill & intangible assets | $41822 | $33010 | $22357 | $26021 |
| Total noncurrent assets | $81125 | $73222 | $65471 | $69101 |
| Total investments | $4236 | $6609 | $6987 | $7338 |
| Total assets | $96628 | $90124 | $81285 | $87174 |
| Current liabilities | ||||
| Accounts payable | $12635 | $11255 | $11136 | $14458 |
| Deferred revenue | ||||
| Short long term debt | $3264 | $3345 | $3564 | $5964 |
| Total current liabilities | $24535 | $22583 | $22054 | $27070 |
| Long term debt | $30269 | $32132 | $29828 | $34176 |
| Total noncurrent liabilities | $43605 | $37134 | $35091 | $38968 |
| Total debt | $33533 | $35477 | $33392 | $40140 |
| Total liabilities | $68140 | $59717 | $57145 | $66038 |
| Shareholders' equity | ||||
| Retained earnings | $33058 | $37801 | $35121 | $34210 |
| Other shareholder equity | -$2993 | -$2805 | -$2109 | -$3771 |
| Total shareholder equity | $20020 | $25275 | $23419 | $20637 |
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $37052 | $36707 | $35422 | |
| Cost of revenue | $30012 | $29937 | $28947 | |
| Gross Profit | $7040 | $6770 | $6475 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7921 | $6851 | $6990 | |
| Total operating expenses | $20211 | $6809 | $6925 | |
| Operating income | -$13171 | -$39 | -$450 | |
| Income from continuing operations | ||||
| EBIT | -$6552 | -$42 | -$176 | |
| Income tax expense | -$782 | -$74 | -$151 | |
| Interest expense | $138 | $99 | $155 | |
| Net income | ||||
| Net income | -$5908 | -$67 | -$180 | |
| Income (for common shares) | -$5908 | -$67 | -$180 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $139081 | $132703 | $132509 | $139537 |
| Cost of revenue | $112009 | $104437 | $104442 | $111520 |
| Gross Profit | $27072 | $28266 | $28067 | $28017 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $34205 | $27295 | $24586 | $27045 |
| Total operating expenses | $33953 | $27295 | $25725 | $26704 |
| Operating income | -$6881 | $971 | $2342 | $1313 |
| Income from continuing operations | ||||
| EBIT | -$4358 | $4707 | $4114 | $1455 |
| Income tax expense | -$1858 | -$30 | $667 | $360 |
| Interest expense | $580 | $400 | $905 | $639 |
| Net income | ||||
| Net income | -$3080 | $4337 | $2542 | $456 |
| Income (for common shares) | -$3080 | $4337 | $2542 | $456 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$5908 | -$67 | -$180 | $118 |
| Operating activities | ||||
| Depreciation | $614 | $616 | $605 | $597 |
| Business acquisitions & disposals | -$119 | -$109 | -$241 | -$259 |
| Stock-based compensation | $48 | $51 | $37 | $55 |
| Total cash flows from operations | -$637 | -$281 | $1039 | -$20 |
| Investing activities | ||||
| Capital expenditures | -$352 | -$506 | -$484 | -$525 |
| Investments | $300 | $427 | $218 | $607 |
| Total cash flows from investing | $817 | $85 | $155 | $334 |
| Financing activities | ||||
| Dividends paid | -$413 | -$415 | -$415 | -$415 |
| Sale and purchase of stock | -$69 | $11 | $12 | |
| Net borrowings | $274 | $205 | -$2858 | -$1159 |
| Total cash flows from financing | -$313 | $186 | -$1460 | -$1193 |
| Effect of exchange rate | $2 | $3 | $4 | |
| Change in cash and equivalents | -$132 | -$10 | -$261 | -$875 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$3080 | $4337 | $2542 | $456 |
| Operating activities | ||||
| Depreciation | $2257 | $1990 | $1973 | $1927 |
| Business acquisitions & disposals | -$7313 | -$2189 | $4096 | -$718 |
| Stock-based compensation | $385 | $391 | $155 | $137 |
| Total cash flows from operations | $2258 | $3899 | $5555 | $5484 |
| Investing activities | ||||
| Capital expenditures | -$2117 | -$1734 | -$1379 | -$1374 |
| Investments | $1767 | $1308 | $856 | $724 |
| Total cash flows from investing | -$3094 | -$1064 | $4072 | -$1297 |
| Financing activities | ||||
| Dividends paid | -$1659 | -$1659 | -$1617 | -$1747 |
| Sale and purchase of stock | -$105 | -$160 | -$51 | -$1534 |
| Net borrowings | -$2703 | $3587 | -$3440 | -$1208 |
| Total cash flows from financing | -$887 | -$1499 | -$9036 | -$4647 |
| Effect of exchange rate | $20 | -$47 | -$66 | -$1 |
| Change in cash and equivalents | -$1702 | $1288 | $525 | -$460 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 3.40 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |